Amnis Receives Cancer Institute Grant

SEATTLE, Dec. 3 -- Amnis, a biotechnology company working on advancements in the imaging of biological cells, announced it has received a $750,000 grant from the National Cancer Institute, a component of the National Institutes of Health.

The two-year grant will be used to develop a velocity detection and autofocus technology for a commercial version of the Amnis's ImageStream technology for imaging cells in flow. An earlier award of $125,000 was used for feasibility studies on the new technique. ImageStream captures images of rapidly moving cells with high sensitivity and in multiple simultaneous imaging modes. These capabilities will enable ultrahigh throughput, multiparametric cellular assays to advance basic research, drug discovery and development and clinical diagnostics, according to Amnis.

For more information, visit: www.amnis.com